Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda
Ronald H Gray, Tom Lutalo, David Serwadda, Nelson K Sewankambo, Maria J Wawer, Fred Wabwire‐Mangen, Mary P. Meehan, &NA; Xianbin, Rakai Project Study Group, Mohammed Kiddugavu, Fred Makumbi, Fred Wabwire-Mangen, Xianbin
Hormonal contraceptives have been associated with increased risk of HIV acquisition.
Methods
The association between hormonal contraception use and HIV acquisition was assessed in a rural community-based cohort in Rakai District, Uganda. A group of 5117 sexually active HIV-negative women were surveyed at 10 month intervals between 1994 and 1999. Information on demographic and sociobehavioral characteristics, use of hormonal contraception (pill and injectable methods), condoms and the number of sexual partners was obtained by home-based interview. HIV incidence rate ratios (IRR) and 95% confidence intervals (CI) associated with hormonal contraception were estimated by multivariate Poisson regression after adjustment for age, condom use, number of sexual partners, marital status, education and history of genital ulcer disease.
Results
At one or more interviews, 16.6% of women reported use of hormonal contraceptives and 23.0% reported condom use. HIV incidence was 2.3/100 person-years in hormonal contraceptive users compared with 1.5/100 person-years in non-hormonal contraceptive users (unadjusted IRR, 1.56; 95% CI, 1.00-2.33). After multivariate adjustment, the IRR associated with hormonal contraceptives was reduced to 0.94 (95% CI, 0.53-1.64). The adjusted IRR was 1.12 (95% CI, 0.48-2.56) with oral contraceptive use and 0.84 (95%CI, 0.41-1.72) with injectable methods.
Conclusion
Use of hormonal contraception is not associated with HIV acquisition after adjustment for behavioral confounding.
hormonal contraceptive HIV acquisition risk Uganda, oral contraceptive injectable HIV incidence Africa, hormonal contraception HIV-1 infection population cohort, Rakai Uganda HIV incidence hormonal contraception, behavioral confounding hormonal contraceptive HIV risk, Kiddugavu Gray hormonal contraception HIV Rakai, Depo-Provera injectable contraceptive HIV acquisition risk, community-based cohort contraceptive use sexually transmitted infection, multivariate Poisson regression contraceptive HIV adjustment, oral contraceptive pill HIV susceptibility epidemiology
PMID 12545084 12545084 DOI 10.1097/00002030-200301240-00014 10.1097/00002030-200301240-00014
Cite this article
Kiddugavu, M., Makumbi, F., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Lutalo, T., Meehan, M., Xianbin, Gray, R. H., & Rakai Project Study Group (2003). Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. *AIDS (London, England)*, *17*(2), 233-240. https://doi.org/10.1097/00002030-200301240-00014
Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS. 2003;17(2):233-240. doi:10.1097/00002030-200301240-00014
Kiddugavu, M., et al. "Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda." *AIDS (London, England)*, vol. 17, no. 2, 2003, pp. 233-240.
Objective: To evaluate the effect of oral and injectable hormonal contraception on the risk of HIV acquisition among women in South Africa and Zimbabwe.
Design: Secondary data analysis of 4913 sexuall...
Contraception/Comparison > Hormonal Contraception > HIV RiskContraception/Comparison > Injectable Contraception > Side EffectsResearch Methodology > Study Design > Secondary Data Analysis
Objectives: We sought to better understand factors associated with ovarian aging in women with HIV (WWH).
Design: HIV has been associated with diminished fertility, younger age at menopause, and short...
Objectives: To investigate the association between hormonal contraceptives and risk of HIV-1 seroconversion and prevalence of other sexually transmitted infections.
Design: Prospective cohort.
Method...
Contraception/Comparison > Injectable Contraceptives > HIV and STI RiskGeneral OB/GYN > Sexually Transmitted Infections > Contraceptive-Associated RiskContraception/Comparison > Safety > Infectious Disease Susceptibility
Background: Combined oral contraceptives (COC) and depot-medroxyprogesterone acetate (DMPA) are among the most widely used family planning methods; their effect on HIV acquisition is not known.
Objec...